Liskiewicz, A. & Müller, T.D. Regulation of energy metabolism through central GIPR signaling. Peptides 176:171198 (2024)
Moser, C.* et al. FAM3D: A gut secreted protein and its potential in the regulation of glucose metabolism. Peptides 167:171047 (2023)
Novikoff, A. & Müller, T.D. The molecular pharmacology of glucagon agonists in diabetes and obesity. Peptides 165:171003 (2023)
Schavinski, A.Z.* et al. Calcitonin gene-related peptide exerts inhibitory effects on autophagy in the heart of mice. Peptides 146:170677 (2021)
Barbosa-Yañez, R.L.* et al. Predictive effect of GIPR SNP rs10423928 on glucose metabolism liver fat and adiposity in prediabetic and diabetic subjects. Peptides 125:170237 (2020)
Knerr, P.J.* et al. Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates. Peptides 125:170225 (2020)
Brandt, S. ; Götz, A. ; Tschöp, M.H. & Müller, T.D. Gut hormone polyagonists for the treatment of type 2 diabetes. Peptides 100, 190-201 (2018)
Brandt, S. ; Mayer, J.P.* ; Ford, J.* ; Gelfanov, V.M.* & DiMarchi, R.D.* Controlled intramolecular antagonism as a regulator of insulin receptor maximal activity. Peptides 100, 18-23 (2018)
Poher, A.-L. ; Tschöp, M.H. & Müller, T.D. Ghrelin regulation of glucose metabolism. Peptides 100, 236-242 (2018)
Santiago, J.C. ; Otto, M.* ; Kern, W.* ; Baier, P.C.* & Hallschmid, M. Relationship between cerebrospinal fluid concentrations of orexin A/hypocretin-1 and body composition in humans. Peptides 102, 26-30 (2018)